BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8421081)

  • 21. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
    Manasco PK; Pescovitz OH; Feuillan PP; Hench KD; Barnes KM; Jones J; Hill SC; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Aug; 67(2):368-72. PubMed ID: 3292562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial male precocious puberty.
    Laue L; Cutler GB
    Curr Ther Endocrinol Metab; 1994; 5():296-9. PubMed ID: 7704737
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
    Crowley WF; Comite F; Vale W; Rivier J; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1981 Feb; 52(2):370-2. PubMed ID: 6780592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a potent, long acting agonist of gonadotropin-releasing hormone in the treatment of precocious puberty.
    Boepple PA; Mansfield MJ; Wierman ME; Rudlin CR; Bode HH; Crigler JF; Crawford JD; Crowley WF
    Endocr Rev; 1986 Feb; 7(1):24-33. PubMed ID: 2937629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome.
    Foster CM; Comite F; Pescovitz OH; Ross JL; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1984 Oct; 59(4):801-5. PubMed ID: 6434582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testolactone-associated high androgen levels, a pharmacologic effect or a laboratory artifact?
    Cummings EA; Salisbury SR; Givner ML; Rittmaster RS
    J Clin Endocrinol Metab; 1998 Mar; 83(3):784-7. PubMed ID: 9506727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome.
    Feuillan PP; Jones J; Oerter KE; Manasco PK; Cutler GB
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1370-3. PubMed ID: 1955519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist.
    Klein KO; Baron J; Barnes KM; Pescovitz OH; Cutler GB
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2387-9. PubMed ID: 9661615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone.
    Pasquino AM; Pucarelli I; Segni M; Matrunola M; Cerroni F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):449-52. PubMed ID: 10022399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience.
    Klein KO; Barnes KM; Jones JV; Feuillan PP; Cutler GB
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4711-6. PubMed ID: 11600530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone release hormone (D-Tryp6-GnRH) in monthly injections. Its possible use in normal puberty.
    Marcondes JA; Abujamra AC; Minanni SL; Mendonca BB; Nery M; Lerario AC; Pereira MA; Abelin N; Wajchenberg BL
    Horm Metab Res; 1993 Feb; 25(2):105-9. PubMed ID: 8458605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy.
    Feuillan PP; Jones JV; Barnes KM; Oerter-Klein K; Cutler GB
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4036-8. PubMed ID: 11095429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of central precocious puberty with an LHRH agonist (Buserelin): effect on growth and bone maturation after three years of treatment.
    Rappaport R; Fontoura M; Brauner R
    Horm Res; 1987; 28(2-4):149-54. PubMed ID: 2969858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term results of long-acting luteinizing-hormone-releasing hormone agonist in central precocious puberty.
    Swaenepoel C; Chaussain JL; Roger M
    Horm Res; 1991; 36(3-4):126-30. PubMed ID: 1840142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty.
    Mansfield MJ; Rudlin CR; Crigler JF; Karol KA; Crawford JD; Boepple PA; Crowley WF
    J Clin Endocrinol Metab; 1988 Jan; 66(1):3-9. PubMed ID: 2961786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty.
    Soriano-Guillén L; Lahlou N; Chauvet G; Roger M; Chaussain JL; Carel JC
    J Clin Endocrinol Metab; 2005 Jan; 90(1):147-51. PubMed ID: 15522928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).
    Juul A; Scheike T; Nielsen CT; Krabbe S; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3059-67. PubMed ID: 7559897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.
    Pescovitz OH; Hench KD; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1988 Sep; 67(3):474-9. PubMed ID: 3137242
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of aromatase inhibitors in precocious puberty.
    Feuillan P; Merke D; Leschek EW; Cutler GB
    Endocr Relat Cancer; 1999 Jun; 6(2):303-6. PubMed ID: 10731123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of deslorelin-induced pubertal delay on the growth of adolescents with short stature and normally timed puberty: preliminary results.
    Municchi G; Rose SR; Pescovitz OH; Barnes KM; Cassorla FG; Cutler GB
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1334-9. PubMed ID: 8077329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.